Last reviewed · How we verify
Pulmonary Edema due to Chronic Heart Failure
Approved treatments
- Spironolacton · ACS Biomarker
- Diuril · Salix Pharms
- Frusemide · Melbourne Health
- Torasemide · Medical University of Warsaw
- Enduron
- Combipres · University Hospital Birmingham
- Microzide · Generic (originally Merck)
Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure. - Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - Bumex
- Zaroxolyn · I3 Pharms
- Lasix · Generic (originally Hoechst AG)
- Edecrin · Bausch Health
- spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pulmonary Edema due to Chronic Heart Failure patent landscape — cliff calendar, originator estates, attackable patents
- Pulmonary Edema due to Chronic Heart Failure treatment landscape brief
- Pulmonary Edema due to Chronic Heart Failure treatment updates RSS
Frequently asked questions about Pulmonary Edema due to Chronic Heart Failure
What drugs treat Pulmonary Edema due to Chronic Heart Failure?
Tracked treatments include Spironolacton, Diuril, Frusemide, Torasemide, Enduron, Combipres, Microzide, Aldactone.
What is the treatment for Pulmonary Edema due to Chronic Heart Failure?
Standard treatment for Pulmonary Edema due to Chronic Heart Failure includes Spironolacton, Diuril, Frusemide, Torasemide, Enduron. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pulmonary Edema due to Chronic Heart Failure patent cliff · Pulmonary Edema due to Chronic Heart Failure CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Diuril · Salix Pharms
- Treatment: Frusemide · Melbourne Health
- Treatment: Torasemide · Medical University of Warsaw
- Treatment: Enduron
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing